[Long-term renal function in Wilms tumor survivors]. 2019

A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
Servicio de Cirugía Pediátrica. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia.

To evaluate long-term renal function and morbimortality in non-syndromic Wilms tumor (WT) survivors. Retrospective study about WT patients treated in 1993-2017, according to SIOP protocols. Mortality, glomerular filtration rate (GFR), prevalence of hypertension and requirement of dialysis and renal transplant were evaluated. Chronic kidney disease (CKD) was defined as GFR <90 ml/min/1.73 m2. Thirty-nine children were treated in the 25 analyzed years. Median time of follow-up was 6 years (0.5-21 years). 48% (19 patients) debuted with stage I or II. Four cases had high-grade histo-logy. Mortality rate was 10%. GFR data were found in 37 patients. Chronic kidney disease (grade I-II) turned up in 6 patients (16%). No patient required renal replacement therapy or renal transplant. 16% of patients developed CKD in both unilateral and bilateral WT, (p>0.05); OR 1.04 (IC 95% 0.09-10.9). Identical results were obtained comparing patients treated with or without radiotherapy (16%). Children with stage I-III had CKD in 11% vs. 40% of patients with stage IV (p=0.12); OR 5.3 (IC 95% 0.61-45). None of them presented hypertension in addition. In the current study the prevalence of CKD was low but not negligible, although no patients required renal replacement therapy or renal transplant. Bilateral renal involvement and radiotherapy were not associated with CKD development. Metastatic disease determines a higher risk of CKD.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D009396 Wilms Tumor A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN. Bilateral Wilms Tumor,Nephroblastoma,Wilms Tumor 1,Wilms' Tumor,Nephroblastomas,Tumor, Bilateral Wilms,Tumor, Wilms,Tumor, Wilms',Wilm Tumor,Wilm's Tumor,Wilms Tumor, Bilateral
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration

Related Publications

A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
October 2017, Pediatric nephrology (Berlin, Germany),
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
May 1991, The Journal of pediatrics,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
February 1998, American journal of clinical oncology,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
July 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
October 2010, International journal of radiation oncology, biology, physics,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
January 1991, Pediatric hematology and oncology,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
November 2015, Cancer,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
July 2015, Cancer,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
June 2001, The Journal of urology,
A Sánchez Sánchez, and O Girón Vallejo, and R Ruiz Pruneda, and M Fernández Ibieta, and V Villamil, and M C Giménez Aleixandre, and C A Montoya-Rangel, and J L Fuster, and J F Pascual Gázquez, and J A Ortega García, and A Cárceles Álvarez, and C Vicente Calderón, and G Zambudio Carmona, and J I Ruiz Jiménez, and J P Hernández Bermejo
August 2016, The Journal of urology,
Copied contents to your clipboard!